This chapter addresses special issues about adverse effects in Cochrane Reviews. Review authors may apply different eligibility criteria when attempting to identify adverse effects data. The two main aspects of eligibility that may differ are the types of study design and the types of participants. It is also possible that studies performed for a different purpose may be eligible for the adverse effects component of the review. When different eligibility criteria are used to address beneficial and adverse effects, it will often be necessary to conduct a separate search for the two (or more) sets of studies, and it may be necessary to plan different methods in other aspects such as assessing risk of bias. Because adverse effects data are oft...
Phillips R, Hazell L, Sauzet O, Cornelius V. Analysis and reporting of adverse events in randomised ...
Adverse (undesirable) effects of interventions should always be considered in EPOC reviews.https://e...
Background: Selective reporting bias (SRB), the incomplete publication of outcomes ...
This chapter addresses special issues about adverse effects in Cochrane Reviews. Review authors may ...
Abstract Background As every healthcare intervention carries some risk of harm, clinical decision ma...
Background: As every healthcare intervention carries some risk of harm, clinical decision making nee...
Objective: To assess how information about adverse events is included in systematic reviews. Study D...
OBJECTIVE: To assess how information about adverse events is included in systematic reviews. STUDY D...
Objective To determine the extent and nature of selective non-reporting of harm outcomes in clinical...
Objectives: To identify methodological research on the incorporation of adverse effects in economic ...
Knowledge about adverse effects of a medication is essential to assess treatment benefits versus ris...
Background: Selective reporting is included as a core domain of Cochrane's tool for assessing risk o...
International audienceOBJECTIVES: Assess the frequency and reasons for disagreements in risk of bias...
To examine the prevalence of consequence stating bias, the selection for publication of a subset of ...
Objectives Assess the frequency and reasons for disagreements in risk of bias assessments for random...
Phillips R, Hazell L, Sauzet O, Cornelius V. Analysis and reporting of adverse events in randomised ...
Adverse (undesirable) effects of interventions should always be considered in EPOC reviews.https://e...
Background: Selective reporting bias (SRB), the incomplete publication of outcomes ...
This chapter addresses special issues about adverse effects in Cochrane Reviews. Review authors may ...
Abstract Background As every healthcare intervention carries some risk of harm, clinical decision ma...
Background: As every healthcare intervention carries some risk of harm, clinical decision making nee...
Objective: To assess how information about adverse events is included in systematic reviews. Study D...
OBJECTIVE: To assess how information about adverse events is included in systematic reviews. STUDY D...
Objective To determine the extent and nature of selective non-reporting of harm outcomes in clinical...
Objectives: To identify methodological research on the incorporation of adverse effects in economic ...
Knowledge about adverse effects of a medication is essential to assess treatment benefits versus ris...
Background: Selective reporting is included as a core domain of Cochrane's tool for assessing risk o...
International audienceOBJECTIVES: Assess the frequency and reasons for disagreements in risk of bias...
To examine the prevalence of consequence stating bias, the selection for publication of a subset of ...
Objectives Assess the frequency and reasons for disagreements in risk of bias assessments for random...
Phillips R, Hazell L, Sauzet O, Cornelius V. Analysis and reporting of adverse events in randomised ...
Adverse (undesirable) effects of interventions should always be considered in EPOC reviews.https://e...
Background: Selective reporting bias (SRB), the incomplete publication of outcomes ...